in a randomised , double-blind study 1258 patients were allocated to receive either anistreplase ( anisoylated plasminogen streptokinase activator complex [ apsac ] , 'eminase ' ) or placebo within 6 h of onset of suspected acute myocardial infarction .
C0078956
anisoylated plasminogen streptokinase activator complex
C0027051
myocardial